Increase/Decrease in Cash: The total change in cash for the company over the given period.
LianBio Sponsored ADR (LIANY) had Increase/Decrease in Cash of $-168.89M for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
-- |
|
$-110.29M |
|
-- |
|
-- |
|
$125.35M |
|
$-125.35M |
|
$14.73M |
|
$-110.62M |
|
$-110.62M |
|
$-110.29M |
|
$-110.29M |
|
$-110.29M |
|
$-110.29M |
|
$-125.35M |
|
$-124.35M |
|
107.92M |
|
107.92M |
|
$-1.02 |
|
$-1.02 |
|
| Balance Sheet Financials | |
$312.77M |
|
$3.12M |
|
$7.19M |
|
$319.96M |
|
$23.61M |
|
-- |
|
$2.70M |
|
$26.31M |
|
$293.65M |
|
$293.65M |
|
$293.65M |
|
107.04M |
|
| Cash Flow Statement Financials | |
$-99.19M |
|
$-69.20M |
|
$1.71M |
|
$248.18M |
|
$79.29M |
|
|
Increase/Decrease in Cash |
$-168.89M |
$19.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-101.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-37.56% |
|
-37.56% |
|
-34.47% |
|
-37.56% |
|
$2.74 |
|
$-0.94 |
|
$-0.92 |
|